Hims & Hers Health Inc’s recent filing unveils that its Chief Legal Officer Boughton Soleil unloaded Company’s shares for reported $34917.0 on Apr 15 ’24. In the deal valued at $13.95 per share,2,503 shares were sold. As a result of this transaction, Boughton Soleil now holds 164,363 shares worth roughly $2.06 million.
Then, Baird Melissa sold 11,751 shares, generating $173,254 in total proceeds. Upon selling the shares at $14.74, the Chief Operating Officer now owns 538,932 shares.
Before that, Baird Melissa sold 11,751 shares. Hims & Hers Health Inc shares valued at $171,372 were divested by the Chief Operating Officer at a price of $14.58 per share. As a result of the transaction, Baird Melissa now holds 538,932 shares, worth roughly $6.76 million.
Jefferies downgraded its Hims & Hers Health Inc [HIMS] rating to a Hold from a a Buy in a research note published on April 16, 2024; the price target was decreased to $15 from $17. A number of analysts have revised their coverage, including Canaccord Genuity’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. Imperial Capital also remained covering HIMS and has increased its forecast on February 28, 2024 with a “an Outperform” recommendation from previously “an In-line” rating. Leerink Partners started covering the stock on February 26, 2024. It rated HIMS as “a Market perform”.
Price Performance Review of HIMS
On Monday, Hims & Hers Health Inc [NYSE:HIMS] saw its stock jump 0.40% to $12.55. Over the last five days, the stock has gained 5.64%. Hims & Hers Health Inc shares have risen nearly 41.01% since the year began. Nevertheless, the stocks have risen 8.75% over the past one year. While a 52-week high of $17.16 was reached on 03/25/24, a 52-week low of $5.65 was recorded on 01/05/24. SMA at 50 days reached $13.69, while 200 days put it at $9.18. A total of 3.67 million shares were traded, compared to the trading of 3.11 million shares in the previous session.
Levels Of Support And Resistance For HIMS Stock
The 24-hour chart illustrates a support level at 12.38, which if violated will result in even more drops to 12.20. On the upside, there is a resistance level at 12.77. A further resistance level may holdings at 12.99. The Relative Strength Index (RSI) on the 14-day chart is 40.02, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.38, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 72.41%. Stochastics %K at 23.37% indicates the stock is a holding.
The most recent change occurred on December 07, 2023 when Imperial Capital began covering the stock and recommended ‘”an In-line”‘ rating along with a $9 price target.
